« Back
Home /
Remdesivir

Remdesivir

Manufacturer	MedChem Express
Category	Infectious Diseases Viral Infections Coronavirus (COVID-19) Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Amount	5 mg
Item no.	HY-104077-5mg
Targets	DNA/RNA Synthesis; SARS-CoV
CASRN	1809249-37-3
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Remdesivir (GS-5734), a nucleoside analogue with effective antiviral activity, has EC50s of 3.3 μM, 4.7 μM, 32 μM, 3.7 μM and 9.2 μM for SARS-CoV-2 and its variants alpha, beta, gamma and delta, respectively. Remdesivir is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro[1][2][3].
StorageTemperature	-20°C, 3 years (Powder)
Shipping	Blue Ice
Manufacturers Applications	COVID-19-anti-virus
MolecularWeight	602.58
Clinical_Information	Launched
Manufacturers Research_Area	Infection
Solubility	DMSO : 100 mg/mL (ultrasonic)
Manufacturers Target	DNA/RNA Synthesis; SARS-CoV
Pathway	Anti-infection; Cell Cycle/DNA Damage
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-104077-5mg-safety-datasheet.pdf